mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-15 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-11 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-11 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-11 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-10 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-10 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-10 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-10 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-10 |